Stocks and Investing
Stocks and Investing
Fri, July 31, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Alethia Young Maintained (AGIO) at Buy with Increased Target to $72 on, Jul 31st, 2020
Alethia Young of Cantor Fitzgerald, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Buy with Increased Target from $70 to $72 on, Jul 31st, 2020.
Alethia has made no other calls on AGIO in the last 4 months.
There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, 0 agree with Alethia's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Alethia
- Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $72 on, Monday, June 15th, 2020
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $82 on, Monday, May 4th, 2020